Leelyn Smith’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-58,625
Closed -$4.17M 161
2026
Q1
$4.17M Buy
58,625
+4,704
+9% +$371K 0.59% 47
2025
Q4
$4.42M Buy
53,921
+2,455
+5% +$191K 0.64% 43
2025
Q3
$3.87M Buy
51,466
+3,252
+7% +$243K 0.58% 43
2025
Q2
$3.57M Buy
48,214
+2,706
+6% +$188K 0.59% 40
2025
Q1
$3.67M Buy
45,508
+2,807
+7% +$241K 0.65% 41
2024
Q4
$3.34M Buy
42,701
+1,727
+4% +$147K 0.59% 42
2024
Q3
$3.85M Buy
+40,974
New +$3.44M 0.69% 40

Other funds holding GEHC

Leelyn Smith's GEHC Position: Q2 2026 in Review

Leelyn Smith sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 58,625 shares — an estimated $4.17M sold.

Leelyn Smith first reported a position in GEHC in Q3 2024 and held it in 7 quarters. The position peaked at $4.42M in Q4 2025. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Leelyn Smith reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
  • Leelyn Smith sold 58,625 GE HealthCare shares in Q2 2026, an estimated $4.17M.
  • Leelyn Smith first reported a position in GE HealthCare in Q3 2024 and held it in 7 quarters.
  • Leelyn Smith's GE HealthCare position peaked at $4.42M in Q4 2025.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Leelyn Smith's 13F filing for Q2 2026, filed 24 Jul 2026.